Logo image of ABAT

AMERICAN BATTERY TECHNOLOGY (ABAT) Stock Fundamental Analysis

NASDAQ:ABAT - Nasdaq - US02451V3096 - Common Stock - Currency: USD

3.37  +0.27 (+8.71%)

After market: 3.33 -0.04 (-1.19%)

Fundamental Rating

2

ABAT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. ABAT has a great financial health rating, but its profitability evaluates not so good. ABAT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ABAT has reported negative net income.
ABAT had a negative operating cash flow in the past year.
In the past 5 years ABAT always reported negative net income.
In the past 5 years ABAT always reported negative operating cash flow.
ABAT Yearly Net Income VS EBIT VS OCF VS FCFABAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

ABAT has a Return On Assets of -78.62%. This is amonst the worse of the industry: ABAT underperforms 93.51% of its industry peers.
ABAT has a worse Return On Equity (-91.63%) than 88.96% of its industry peers.
Industry RankSector Rank
ROA -78.62%
ROE -91.63%
ROIC N/A
ROA(3y)-53.21%
ROA(5y)-2877.88%
ROE(3y)-62.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABAT Yearly ROA, ROE, ROICABAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ABAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABAT Yearly Profit, Operating, Gross MarginsABAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K

More info and screens

7

2. Health

2.1 Basic Checks

ABAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ABAT has been increased compared to 1 year ago.
Compared to 5 years ago, ABAT has more shares outstanding
The debt/assets ratio for ABAT is higher compared to a year ago.
ABAT Yearly Shares OutstandingABAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ABAT Yearly Total Debt VS Total AssetsABAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 9.40 indicates that ABAT is not in any danger for bankruptcy at the moment.
The Altman-Z score of ABAT (9.40) is better than 80.52% of its industry peers.
There is no outstanding debt for ABAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.4
ROIC/WACCN/A
WACC9.85%
ABAT Yearly LT Debt VS Equity VS FCFABAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

ABAT has a Current Ratio of 2.19. This indicates that ABAT is financially healthy and has no problem in meeting its short term obligations.
ABAT has a Current ratio (2.19) which is in line with its industry peers.
A Quick Ratio of 2.17 indicates that ABAT has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.17, ABAT is doing good in the industry, outperforming 62.99% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.19
Quick Ratio 2.17
ABAT Yearly Current Assets VS Current LiabilitesABAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.09% over the past year.
EPS 1Y (TTM)0.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y103.73%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1845.23%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABAT Yearly Revenue VS EstimatesABAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 20M 40M 60M 80M 100M
ABAT Yearly EPS VS EstimatesABAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2023 2024 2025 0 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ABAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 110.13, the valuation of ABAT can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as ABAT.
Compared to an average S&P500 Price/Forward Earnings ratio of 37.54, ABAT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 110.13
ABAT Price Earnings VS Forward Price EarningsABAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABAT Per share dataABAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ABAT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN BATTERY TECHNOLOGY

NASDAQ:ABAT (7/24/2025, 6:23:25 PM)

After market: 3.33 -0.04 (-1.19%)

3.37

+0.27 (+8.71%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)09-22 2025-09-22/amc
Inst Owners9.86%
Inst Owner Change-0.15%
Ins Owners5%
Ins Owner Change12.66%
Market Cap309.67M
Analysts82.86
Price Target9.18 (172.4%)
Short Float %8.33%
Short Ratio3.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-97.76%
Min Revenue beat(2)-98.39%
Max Revenue beat(2)-97.13%
Revenue beat(4)0
Avg Revenue beat(4)-96.91%
Min Revenue beat(4)-98.52%
Max Revenue beat(4)-93.6%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 110.13
P/S 166.68
P/FCF N/A
P/OCF N/A
P/B 4.72
P/tB 4.78
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)0.03
Fwd EY0.91%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.02
BVpS0.71
TBVpS0.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.62%
ROE -91.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.21%
ROA(5y)-2877.88%
ROE(3y)-62.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.26%
Cap/Sales 157.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.19
Quick Ratio 2.17
Altman-Z 9.4
F-Score5
WACC9.85%
ROIC/WACCN/A
Cap/Depr(3y)15252%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.71%
EPS Next Y103.73%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1845.23%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-99.45%
OCF growth 3YN/A
OCF growth 5YN/A